ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Analysis of the competitiveness of the biological pharmaceutical industry on the example of the United States

Journal: RUDN Journal of Economics (Vol.31, No. 2)

Publication Date:

Authors : ; ;

Page : 238-252

Keywords : bio pharmaceutical industry economy; biomedicine; China; USA; international competitiveness; Porter Diamond Model;

Source : Download Find it from : Google Scholarexternal

Abstract

Since entering the era of bioeconomy, the biotechnology industry economy represented by the bio pharmaceutical industry is leading a new wave of technological revolution. China’s strategic deployment for the bio pharmaceutical industry economy has achieved remarkable results, but there is still a large competitive gap compared with the United States and other biomedical powers. The goal of this article is to study the American biomedical market and find out the gap, so as to provide inspiration for the development of the biomedical industry in China and other countries. The Porter Diamond Model is used to build the theoretical research method analysis framework of the international competitiveness of the bio pharmaceutical industry. Taking the United States as an example, the paper analyzes its competitive advantages in six aspects: the elements of the biomedical industry, the enterprise structure and competition, the demand conditions, the relevant and supporting industries, the government and development opportunities. Based on this, the paper puts forward policy recommendations conclusions for China’s development of the bio pharmaceutical industry, so as to provide reference value for the development of the pharmaceutical industry.

Last modified: 2023-07-07 19:05:26